Breast

Insufficient/inadequate category in breast cytology: Are the standardized guidelines of rapid on‐site evaluation available to reduce its rate?

“…ROSE decreases the number of insufficient/inadequate samples in breast cytology to <1%, with a good agreement between on‐site immediate and final diagnoses 21 . ROSE also helps on‐site determination of whether additional FNA attempts are needed or not.…”

“…20 ROSE decreases the number of insufficient/inadequate samples in breast cytology to <1%, with a good agreement between on-site immediate and final diagnoses. 21 ROSE also helps on-site determination of whether additional FNA attempts are needed or not. The additional sampling from lesions may also be aspirated for ancillary tests after evaluating the ROSE findings.…”

“…ROSE also helps on‐site determination of whether additional FNA attempts are needed or not. The additional sampling from lesions may also be aspirated for ancillary tests after evaluating the ROSE findings 21 . During the ROSE, the consistency of lesions/lump (Soft, Firm, or Hard), change in lesion size post‐aspiration, the color of aspirate (Bloody, Clear, Green, Others), consistency of aspirate (Viscous, Thin fluid, Mucoid, other), and cellularity also be assessed 21 …”

“…The additional sampling from lesions may also be aspirated for ancillary tests after evaluating the ROSE findings. 21 During the ROSE, the consistency of lesions/lump (Soft, Firm, or Hard), change in lesion size postaspiration, the color of aspirate (Bloody, Clear, Green, Others), consistency of aspirate (Viscous, Thin fluid, Mucoid, other), and cellularity also be assessed. 21 Unstained smear examination has been proven to be useful in determining sample adequacy by Hemalatha et al 22 and Prayaga et al 23 the other way to reduce high numbers of inadequate samples.…”